Country - Poland
Summary - Successive Delivery Of A Medicinal Product Containing The Active Substance Rituximab
Deadline - login to view
MT reference number - 90439645
Product classification - Pharmaceutical products
Address - Poland
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 90439645
Document Type - Tender Notices
Description - Description: 1.The subject of the order is the successive delivery of a medicinal product containing the active substance rituximab (MabThera 100mg) for the implementation of a non-commercial clinical trial:."Early treatment with rituximab in childre n with idiopathic nephrotic syndrome" Eng. "ERICONS - Early RITUXIMAB in Childhood Onset Nephrotic Syndrome" as part of the Medical Research Agency (ABM) Competition for the implementation of research and scientific projects in the field of non-commercial clinical trials. The Medical University of Gdańsk acts as the Sponsor of the non-commercial clinical trial (in accordance with the assumptions of Good Clinical Practice, GCP).2. A detailed desc
Mt Ref Id - 90439645
Deadline - Nov 30, -0001
Similar Tenders :
Healthcare and Medicine